The Association of the British Pharmaceutical Industry (ABPI)

There are real benefits for care when pharmaceutical companies partner with the NHS. #SanofiUK worked with The Newcastle Upon Tyne Hospitals NHS Foundation Trust to improve asthma care. Read more in our case study library + see guidance on running successful partnerships https://bit.ly/46BPaHt #PowerofPartnerships

The Innovation Ecosystem report is out today. It recognises that innovation is key to meeting growing healthcare demands, and I’m proud to say I think our industry can help the NHS meet those demands and provide the innovations the report talks about. 20 percent of all private sector R&D in the UK occurs in life sciences firms, creating an estimated 50,000 new jobs in the sector in the 5 years to 2022. (From the report) So what’s holding us back? As the report says, there is a need to significantly increase the capacity, capability and skills of the NHS workforce to undertake innovation work. If we get this right, the opportunities are significant. The life sciences sector’s collaboration with the NHS offers a pathway for transformative healthcare. It is important for the NHS 10-Year Plan and the Innovation and Adoption Strategy to take the report’s recommendations forward to help the NHS genuinely lead healthcare innovation on a global scale. Congrats to Roland Sinker who led the work and the NHSE team for getting this out today. Read the report here https://lnkd.in/exxaedcT

The Innovation Ecosystem report is out today. It recognises that innovation is key to meeting growing healthcare demands, and I’m proud to say I think our industry can help the NHS meet those demands and provide the innovations the report talks about. 20 percent of all private sector R&D in the UK occurs in life sciences firms, creating an estimated 50,000 new jobs in the sector in the 5 years to 2022. (From the report) So what’s holding us back? As the report says, there is a need to significantly increase the capacity, capability and skills of the NHS workforce to undertake innovation work. If we get this right, the opportunities are significant. The life sciences sector’s collaboration with the NHS offers a pathway for transformative healthcare. It is important for the NHS 10-Year Plan and the Innovation and Adoption Strategy to take the report’s recommendations forward to help the NHS genuinely lead healthcare innovation on a global scale. Congrats to Roland Sinker who led the work and the NHSE team for getting this out today. Read the report here https://lnkd.in/exxaedcT

Our colleague Brian Duggan is at the ICS Network National conference today, where he's been catching up with Sarah Walter and Matthew Taylor. Discussions today recognised the value of NHS-industry partnerships, which if done right, benefit patients, the NHS and the company concerned. Read our joint guidance with the NHS Confederation on how to make partnerships a success: https://bit.ly/46BPaHt

Delighted to have spoken on behalf of The Association of the British Pharmaceutical Industry (ABPI) at The King's Fund #KFLifeSciences conference this week with Charlotte Wickens, Verena Stocker, Harriet Smith and Kristin Anne Rutter on enabling effective partnerships between the NHS and industry.

'Just do it. There's a high likelihood that by working together you will achieve something greater than the sum of your parts individually.' Tom Nutt, CEO of Meningitis Now reflected on NHS-industry partnerships at our Life Sciences Event earlier this week. Our full report on the benefits and challenges of NHS-industry partnerships can be found here: https://lnkd.in/eKpMbXyp

Read today's thoughtful article on NHS-industry partnerships from Anna Charles at The King's Fund. As she says, effective collaboration between the NHS and industry is not without challenges and requires effort to get right, but "at their best, industry partnerships can be powerful catalysts for improvements in care, bringing the NHS access to resources to pump-prime change, and to a depth and breadth of skills and expertise..." Read more in the Health Service Journal https://lnkd.in/e5GCAibS?

Our Chief Executive Richard Torbett MBE, Director of Strategic Partnerships Brian Duggan and Medical Director Amit Aggarwal participated in excellent discussions at The King's Fund's Life Sciences conference yesterday. Great to hear a range of perspectives on how industry and the NHS can best work together for the benefit of patients, what the barriers are, and how to solve them. Many thanks to The King's Fund for bringing the NHS, industry, charities and others together to discuss these important issues.

We warmly welcome Professor Anthony Harnden on his new appointment as Chair for the Medicines and Healthcare products Regulatory Agency. Our industry stands ready to support him and the wider MHRA in continuing to deliver the highest UK quality and safety standards alongside timely patient access to new medicines and technologies. Read our full response here: https://lnkd.in/e5tWTDdR

I am delighted to have worked with Anna Charles and The King's Fund on this important piece of work published today which highlights how partnerships between the NHS and industry can make a real difference to improving patient care and NHS performance.   The report explores four successful projects that have delivered tangible benefits for patients and the NHS across England. These include: 🖋️ Improving outcomes for people with diabetes following acute coronary syndrome in Lincolnshire with Boehringer Ingelheim). 🖋️ Eliminating hepatitis C among people in contact with drug and alcohol services across the NHS Addictions Provider Alliance (with Gilead Sciences). 🖋️ Improving asthma care in Greater Manchester (with AstraZeneca). 🖋️ Enhancing the front-end skin cancer pathway in Lancashire and South Cumbria (with Sanofi). I’ve also written a blog, published today, on how we capitalise on these opportunities and deliver on the ambitions of the NHS and the Government. To read my blog, click here: https://bit.ly/48XxLtL   To read the full report, click here: https://bit.ly/3OeKcI9 To read the ABPI’s response to the report, click here: https://bit.ly/4fwjCq8